Gtf E Learning November

25 Questions | Total Attempts: 121

SettingsSettingsSettings
Please wait...
Gtf E Learning November

Welcome to November E-Learning TestHere is an opportunity to test your own Product knowledge and Strategy. You have 20 minutes to complete this test. Please enter your name and Emp. Code and press "Start" to begin the test. You can only attend the test once and hence make sure you have uninterrupted internet connectivity. All the bestMicro Leadership Academy


Questions and Answers
  • 1. 
    What is GERD?
    • A. 

      Gastro Esophageal Reflux disease

    • B. 

      Reflux eosphagitis

    • C. 

      LES disease

    • D. 

      Regurgitation

  • 2. 
    What is Peptic Ulcer?
    • A. 

      Duodenal Ulcer

    • B. 

      Gastric Ulcer

    • C. 

      Oesophageal Ulcer

    • D. 

      Both 1 & 2

  • 3. 
    Action of UDCA in Udibon is…
    • A. 

      Cholorectic Action

    • B. 

      Dissolution of Gall Stones

    • C. 

      Antioxidant action

    • D. 

      All of the above

  • 4. 
    Silybon has…
    • A. 

      Antiviral action

    • B. 

      Antifibrotic activity

    • C. 

      Regenerates partially damaged hepatocytes

    • D. 

      All the above

  • 5. 
    Indications for Silybon are…
    • A. 

      Viral Hepatitis in Adults and Children

    • B. 

      Alcoholic Cirrhosis

    • C. 

      DASH

    • D. 

      All of the above

  • 6. 
    Dolo 650 is  suitable for elderly patients
    • A. 

      No gastric irritation

    • B. 

      No headache

    • C. 

      No hypotension

    • D. 

      Safe in pregnancy

  • 7. 
    Dolo drops is safe
    • A. 

      Free from harmful excipients

    • B. 

      Very tasty

    • C. 

      Dosage convenience

    • D. 

      UK MHRA recommended strength

  • 8. 
    DOLO 650 is indicated in Fever due to
    • A. 

      Malaria /Chikingunya

    • B. 

      H1N1

    • C. 

      Typhoid

    • D. 

      All of the above

  • 9. 
    Aceclofenac in DOLOWIN acts by
    • A. 

      Inhibiting COX

    • B. 

      Inhibits Interleukin 1 & TNF alpha

    • C. 

      Inhibits metalloproteinase

    • D. 

      All of the above

  • 10. 
    Advantage of Drotaverine over Dicyclomine is …
    • A. 

      No anticholinergic effects

    • B. 

      BID dose

    • C. 

      Acts at cellular level

    • D. 

      All of the above

  • 11. 
    Drotaverine is a …
    • A. 

      Smooth muscle relaxant

    • B. 

      Neurotransmitter

    • C. 

      Antimuscarinic action

    • D. 

      Acts on the nervous system

  • 12. 
    Levosulpiride in Esofag L  has…
    • A. 

      Prokinetic action

    • B. 

      Anti emetic action

    • C. 

      Safer than cisapride & Metaclopromide

    • D. 

      All of the above

  • 13. 
    Indications for EBAST are 
    • A. 

      Seasonal Allergic Rhinitis (SAR)

    • B. 

      Perennial Allergic Rhinitis (PAR)

    • C. 

      Chronic Idiopathic Urticaria

    • D. 

      All of the above

  • 14. 
    Dolowin Spas is indicated in Abdominal Spasm due to
    • A. 

      Intestinal colic

    • B. 

      Biliary Colic

    • C. 

      Renal Colic & dysmennorhoea

    • D. 

      All of the above

  • 15. 
    Dolowin Forte composition is
    • A. 

      Acelclofenac 100mg,Paracetamol325mg,Serratiopeptidase 15mg

    • B. 

      Acelclofenac 100mg,Paracetamol500mg,Serratiopeptidase 15mg

    • C. 

      Acelclofenac 100mg,Paracetamol375mg,Serratiopeptidase 15mg

    • D. 

      Acelclofenac 100mg,Paracetamol325mg,Serratiopeptidase 15mg

  • 16. 
    Montelukast in Ebast M
    • A. 

      Exerts anti-inflammatory action by inhibiting leukotriene

    • B. 

      Non sedative

    • C. 

      Controls allergy

    • D. 

      Longer inhibition of Wheal & Flare

  • 17. 
    Phenylepherine in Ebast DC is
    • A. 

      Proven Nasal Decongestant

    • B. 

      Proven Anti allergic

    • C. 

      New generation H1 blocker

    • D. 

      Resolves Allergic Rhinitis

  • 18. 
    Levosulpiride  in Esofag L provides
    • A. 

      Better control of Diabetic Gastroparesis

    • B. 

      Effective in Gastric ulcer

    • C. 

      Effective in Duodenal Ulcer

    • D. 

      Globally accepted PPI

  • 19. 
    Domperidone in Esofag D
    • A. 

      Has Prokinetic Action

    • B. 

      Reduces secretion of HCl

    • C. 

      Inhibits Proton Pump

    • D. 

      Acts on pareital cells

  • 20. 
    Clavulanic Acid in Gramocef CV is…
    • A. 

      Beta lactamase inhibitor

    • B. 

      Has added antibiotic effect

    • C. 

      Has antioxidant benefits

    • D. 

      Reduces side effects of Cefixime

  • 21. 
    Ofloxacin in Gramocef OF acts by
    • A. 

      Inhibiting DNA gyrase

    • B. 

      By inhibiting proteins

    • C. 

      Kills bacteria faster

    • D. 

      3rd generation antibiotic

  • 22. 
    Cefixime in Gramocef OF acts by
    • A. 

      Inhibiting Peptidoglycan (cell wall synthesis)

    • B. 

      Superior to Ofloxacin

    • C. 

      Superior to all antibiotics

    • D. 

      Very useful in STD infections

  • 23. 
    Microdox LBX is useful in
    • A. 

      Pelvic Inflammatory Disease (PID)

    • B. 

      Acne

    • C. 

      Dental Infections

    • D. 

      All of the above

  • 24. 
    Lactobacillus in Microdox LBX 
    • A. 

      Reduces risk of diarrhoea and improves stool consistency during antibiotic therapy

    • B. 

      Has added antibiotic action

    • C. 

      Reduces the dose of Microdox LBX

    • D. 

      Improves the spectrum of Microdox LBX

  • 25. 
    Levobact has been appoved by US FDA in the treatment of
    • A. 

      Nosocomial Pneumonia & CAP

    • B. 

      STD infections

    • C. 

      URTI

    • D. 

      SSTI

Back to Top Back to top